The new strategy for preventing postoperative recurrence in non-small cell lung cancer patients
Project/Area Number |
25861242
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory surgery
|
Research Institution | Aichi Cancer Center Research Institute |
Principal Investigator |
MAEDA Ryo 愛知県がんセンター(研究所), 分子病態学部, リサーチレジデント (00648769)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 肺癌 |
Outline of Final Research Achievements |
Bone marrow-derived circulating myelomonocytic CD14-positive (CD14+) cells have been reported to infiltrate tumors and are commonly referred to as tumor-associated macrophages. In this study, we demonstrated that circulating CD14+CD204+ cells from the primary tumor facilitated the metastasis of cancer cells at distant sites.
|
Report
(3 results)
Research Products
(1 results)